知镜 Cognispect · 医学文献与研究工作台

[Pulmonary hypertension associated with interstitial lung diseases: current state of the art].

Lozina A, Maloir Q, Parzibut G, Gester F, Dulgheru RE, Petitjean H, Davidsen C, Lancellotti P, Defourny C, Desir C, Canivet P, Louis R, Guiot J.
Revue medicale de Liege · 2026-10-01 · PMID 42861537

文献摘要

Pulmonary hypertension associated with interstitial lung diseases (PH-ILD) is a common and severe complication of interstitial lung diseases. Diagnosis is challenging and relies on a combination of clinical, functional, biological, radiological and echocardiographic findings. Definitive diagnosis is established by right heart catheterisation, which confirms the presence of pre-capillary pulmonary hypertension associated with increased pulmonary vascular resistance. Until 2021, and the INCREASE study, all randomised controlled trials evaluating therapies approved for pulmonary arterial hypertension in patients with PH-ILD yielded disappointing results. However, recent advances exploring the potential of novel therapeutic strategies have renewed interest in PH-ILD, with a progressive paradigm shift opening new perspectives for a condition that was until recently associated with a poor prognosis.

在知镜精读原文来源

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。